World's Best Scientists 2026 revealed!
Claude C.A. Bernard

Claude C.A. Bernard

D-Index & Metrics

Immunology

D-Index
71
Citations
18838
World Ranking
2307
National Ranking
91

Claude C.A. Bernard publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claude C.A. Bernard sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 261 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claude C.A. Bernard D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claude C.A. Bernard sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1998 - Fellow of American Physical Society (APS) Citation For his many contributions to the numerical study of quantum chromodynamics, particularly of the weak decays of strongly interacting particles
  • 1980 - Fellow of Alfred P. Sloan Foundation

Overview

Claude C.A. Bernard is a researcher affiliated with Monash University in Australia. Their work spans various fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. The interdisciplinary nature of their research touches on several specialized subfields such as Immunology, Cellular and Molecular Neuroscience, Molecular Biology, Ophthalmology, and Genetics.

Several recurring themes appear in their main topics of study. These include Nuclear Receptors and Signaling, Diabetes and associated disorders, Diabetes Management and Research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Immune Cells in Cancer.

The scientist's recent publications demonstrate a focus on immunological and molecular mechanisms as well as disease treatment approaches. Notable papers include:

  • Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study (2020) published in Diabetologia
  • Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity (2021) published in Nanomedicine Nanotechnology Biology and Medicine
  • Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP+ treated SH-SY5Y Parkinson's model (2022) published in Non-coding RNA Research
  • TGFβ and Wnt Signaling Pathways Cooperatively Enhance Early Dopaminergic Differentiation of the Unrestricted Somatic Stem Cells (2020) published in Journal of Molecular Neuroscience
  • Frequency of Eye Diseases in Subjects Aged 40 and Over (2025) published in Open Journal of Ophthalmology

Collaboration plays a role in their research, with frequent co-authors including Azita Parvaneh Tafreshi, Michèlle Rosenzwajg, Randa Salet, Roberta Lorenzon, and Nicolas Tchitchek.

The distribution of publications aligns with venues such as Diabetologia, Nanomedicine Nanotechnology Biology and Medicine, Non-coding RNA Research, Journal of Molecular Neuroscience, and Open Journal of Ophthalmology.

Throughout their career, Claude C.A. Bernard has been recognized by awards such as Fellow of the American Physical Society in 1998, which acknowledged their contributions to the numerical study of quantum chromodynamics, focusing on weak decays of strongly interacting particles. They were also named a Fellow of the Alfred P. Sloan Foundation in 1980.

Best Publications

  • The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

    Dorothée Chabas;Sergio E. Baranzini;Dennis Mitchell;Claude C. A. Bernard

  • IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

    David O. Willenborg;Sue Fordham;C. C A Bernard;William B. Cowden

  • TNF IS A POTENT ANTI-INFLAMMATORY CYTOKINE IN AUTOIMMUNE-MEDIATED DEMYELINATION

    Junliang Liu;Michael W. Marino;Grace Wong;Dianne Grail

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

    Veronika Brundula;N Barry Rewcastle;Luanne M Metz;Claude Charles Andre Bernard

  • Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis

    Jonathan Luke McQualter;Rima Darwiche;Christine Ewing;Manabu Onuki

  • Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients

    Jorge R. Oksenberg;Simon Stuart;Ann B. Begovich;Robert B. Bell

  • Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

    Jorge R. Oksenberg;Michael A. Panzara;Ann B. Begovich;Dennis Mitchell

  • MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

    Nicolas Molnarfi;Ulf Schulze-Topphoff;Martin S Weber;Juan C Patarroyo

  • Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    Agnès Hartemann;Gilbert Bensimon;Christine A Payan;Sophie Jacqueminet

  • Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

    N Kerlero de Rosbo;R Milo;M B Lees;D Burger

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

    Sergio E. Baranzini;Matthew C. Jeong;Catalin Butunoi;Ronald S. Murray

  • Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

    C. C. A. Bernard;T. G. Johns;A. Slavin;M. Ichikawa

  • B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

    Martin S. Weber;Thomas Prod'homme;Juan C. Patarroyo;Nicolas Molnarfi

  • Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy

    Lawrence Steinman;Roland Martin;Claude Charles Andre Bernard;Paul Conlon

  • The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.

    Tara Karnezis;Tara Karnezis;Wim Mandemakers;Jonathan L McQualter;Binhai Zheng

  • Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.

    William H. Robinson;Paulo Fontoura;Byung J. Lee;Henry E Neuman De Vegvar;Henry E Neuman De Vegvar

  • IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.

    Yoshinobu Okuda;Saburo Sakoda;Claude C. A. Bernard;Harutoshi Fujimura

  • T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

    Jorge R. Oksenberg;Martina Sherritt;Ann B. Begovich;Henry A. Erlich

Frequent Co-Authors

Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
Lawrence Steinman
Lawrence Steinman Stanford University
Scott S. Zamvil
Scott S. Zamvil University of California, San Francisco
Terrance Grant Johns
Terrance Grant Johns Telethon Kids Institute
Raymond A. Sobel
Raymond A. Sobel Stanford University
John S. Forsythe
John S. Forsythe Monash University
Richard L. Boyd
Richard L. Boyd Monash University
Michelle Rosenzwajg
Michelle Rosenzwajg Sorbonne University
David J. Craik
David J. Craik University of Queensland
Sergio E. Baranzini
Sergio E. Baranzini University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing related nursing degrees online is a practical option. Many programs cater to different starting points and career goals, including options for individuals with no prior nursing background. Exploring online absn programs for non nurses offers a fast track into the nursing field for career changers, combining foundational knowledge with clinical practice.

If you’re looking to accelerate your entry into nursing, numerous accelerated programs are available. Among these, the 12-month accelerated nursing programs stand out for those aiming to complete their Bachelor of Science in Nursing (BSN) in a reduced timeframe without sacrificing quality.

Programs for Licensed Practical Nurses (LPNs) can also provide a stepping stone into the broader nursing profession. Identifying which lpn programs are easiest to get into allows prospective students to make informed decisions based on admission criteria and program flexibility.

For advanced nursing roles, considering the easiest nurse practitioner program can help nurses elevate their career while balancing work and study. These programs offer pathways to specialized practice areas, complementing a strong foundation in oncology, immunology, or infectious diseases.

Best Scientists Citing Claude C.A. Bernard

Trending Scientists

Recently Published Articles